Neurizon (ASX:NUZ) has officially snagged a U.S. patent for its neurodegenerative disease and cancer drug candidate NUZ-001, ...
From the first note of 'Tomorrow' to the final curtain call, Annie at Clowes Memorial Hall is a dazzling and joyous ...
Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback